廣譽遠(600771.SH):已經開展相關產品在增強免疫力、延緩衰老等方面的循證醫學研究
格隆匯5月29日丨廣譽遠(600771.SH)在投資者互動平臺表示,龜齡集爲公司獨家品種,是國藥準字號處方藥,功能主治爲:強身補腦,固腎補氣,增進食慾。該產品組方融合二十八星宿與自然四時規律,組方精妙,療效確切,溫補腎陽只是功效之一。公司已經開展了該產品在增強免疫力、延緩衰老等方面的循證醫學研究,且已有相關學術成果的落地。公司未來會持續開展學術成果背書產品在銷售推廣等方面的工作,進一步凸顯該獨家品種的核心價值。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.